Cargando…

Extra-respiratory manifestations of COVID-19

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most patients with COVID-19 manifest fever and respiratory tract symptoms, SARS-CoV-2 infection may also involve other organs/systems and present w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Chih-Cheng, Ko, Wen-Chien, Lee, Ping-Ing, Jean, Shio-Shin, Hsueh, Po-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243791/ https://www.ncbi.nlm.nih.gov/pubmed/32450197 http://dx.doi.org/10.1016/j.ijantimicag.2020.106024

Ejemplares similares

Treatment options for COVID-19: The reality and challenges
por: Jean, Shio-Shin, et al.
Publicado: (2020)

How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Monkeypox: An emerging global threat during the COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

How to Keep COVID-19 at Bay: A Taiwanese Perspective
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Increased antimicrobial resistance during the COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Use of Multiple Doses of Intravenous Infusion of Umbilical Cord-Mesenchymal Stem Cells for the Treatment of Adult Patients with Severe COVID-19-Related Acute Respiratory Distress Syndrome: Literature Review
por: Hsueh, Po-Ren, et al.
Publicado: (2023)

Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
por: Jean, Shio-Shin, et al.
Publicado: (2018)

In Vitro Susceptibilities of Worldwide Isolates of Intrapulmonary Aspergillus Species and Important Candida Species in Sterile Body Sites against Important Antifungals: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2017–2020
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19
por: Lee, Ping-Ing, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
por: Chen, Hsin-Yu, et al.
Publicado: (2021)

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Evolving reporting criteria of COVID-19 in Taiwan during the epidemic
por: Huang, Yhu-Chering, et al.
Publicado: (2020)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

In vitro diagnostics of coronavirus disease 2019: Technologies and application
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Beyond mental stress-induced myocardial ischemia following the COVID-19 vaccine
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

COVID-19: Pulmonary and Extra Pulmonary Manifestations
por: Elrobaa, Islam H., et al.
Publicado: (2021)

Are children less susceptible to COVID-19?
por: Lee, Ping-Ing, et al.
Publicado: (2020)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
por: Johnson, Kemmian D., et al.
Publicado: (2020)

Paralytic Ileus as an Extra-Pulmonary Manifestation of COVID-19
por: Moghimi, Navid, et al.
Publicado: (2023)

SARS-CoV-2 and COVID-19
por: Sheng, Wang-Huei, et al.
Publicado: (2020)

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
por: Jean, Shio-Shin, et al.
Publicado: (2020)

Extra-Articular Manifestations in Reactive Arthritis due to COVID-19
por: Santacruz, Juan Camilo, et al.
Publicado: (2021)

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
por: Lee, Ping-Ing, et al.
Publicado: (2020)

A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
por: Chen, Po-Lin, et al.
Publicado: (2020)

Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Respiratory etiological surveillance among quarantined patients with suspected lower respiratory tract infection at a medical center in southern Taiwan during COVID-19 pandemic
por: Huang, Chien-Ping, et al.
Publicado: (2022)

In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Extra-muscular manifestations of TK2 deficiency
por: El-Hattab, Ayman W., et al.
Publicado: (2018)

Changing Epidemiology of Respiratory Tract Infection during COVID-19 Pandemic
por: Tang, Hung-Jen, et al.
Publicado: (2022)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_je6aucqlght7737osl3klf6vk1